Composition for wound healing comprising extracts of Grateloupia angusta
A red bone marrow extract from Grateloupia angusta addresses the limitations of existing wound treatments by enhancing angiogenesis and collagen synthesis, effectively promoting wound healing in a safe and effective manner.
KR1020260113445APending Publication Date: 2026-07-21CATHOLIC KWANDONG UNIV IND FOUND
View PDF 0 Cites 0 Cited by
Patent Information
- Authority / Receiving Office
- KR · KR
- Patent Type
- Applications
- Current Assignee / Owner
- CATHOLIC KWANDONG UNIV IND FOUND
- Filing Date
- 2025-01-13
- Publication Date
- 2026-07-21
AI Technical Summary
Technical Problem
Existing wound treatment methods using growth factors and cytokines are inadequate due to the complexity of wound healing processes and risks associated with mesenchymal stem cell culture medium, such as low cytokine and growth factor secretion, contamination, and exposure to animal-derived products.
Method used
A pharmaceutical composition utilizing red bone marrow extract from Grateloupia angusta, a marine red algae, which enhances angiogenesis and collagen synthesis without cytotoxicity, is developed for wound treatment.
Benefits of technology
The red bone marrow extract promotes wound healing by increasing angiogenesis and collagen production, demonstrating therapeutic efficacy in both in vitro and in vivo models without adverse effects.
✦ Generated by Eureka AI based on patent content.
Smart Images
Figure PAT00006_ABST
Abstract
The present invention relates to a wound treatment composition comprising a red bone marrow extract. More specifically, the red bone marrow extract of the present invention can be utilized in the treatment of wounds because it increases angiogenesis and enhances collagen synthesis ability without cytotoxicity, thereby improving the function of skin fibroblasts.
Need to check novelty before this filing date? Find Prior Art